Tag Archives: Chris Viehbacher

EFPIA Promises Stronger Ties with China

The European Federation of Pharmaceutical Industries and Associations (EFPIA) reports that it has “strengthened its commitment in China”. Federation delegates are this week concluding a visit to Beijing to establish “a better understanding of the numerous healthcare reforms underway in China … and explore closer paths of cooperation in global drug development between China and […]
Posted in Europe, Events, Global, Regulatory | Also tagged , , | Leave a comment

BIO 2012: The Case for Collaboration

Rodney King died on Sunday, but his famous question lives on: “Can we all get along?” At BIO 2012, the proposition seems to be: “Can we all just collaborate?”
Posted in Biotech, Europe, Events, FDA, Global, healthcare, IP, leadership, People, R&D, Regulatory, Strategy, Technology | Also tagged , , , , , , | Leave a comment

Pharma Leads the Pack in July Job Losses

Springtime optimism and the gentle steam of a perceived economic recovery in the US has all but dissipated, with the blanketing heat of deficit politics and a job situation that’s anything but august. In July, the US pharmaceutical industry shed 13,493 jobs, more than any other sector, according to an updated Challenger, Gray & Christmas […]
Posted in leadership, Strategy | Also tagged , | 1 Comment

Sanofi Executive Change Up

Barely a week after former Glaxo executive Chris Viehbacher assumed the role of CEO, Sanofi-Aventis announced that Jean-Claude Leroy, the company’s executive vp of finance and legal, has left the company. In a short statement, the company noted that his position will be filled by two people, reporting directly to Viehbacher; they are CFO Laurence […]
Posted in People | Also tagged , , , , | Leave a comment
  • Categories

  • Meta